INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Inogen Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.55+0.30 (+4.80%)
Close on Oct 19, 2026
- Market cap
- $177.15M
- P/E (TTM)
- –
- Dividend yield
- –
Inogen Inc revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $204.46M | $206.99M | $209.84M | $212.40M | $214.92M | $216.80M | $218.50M | $221.10M | $222.95M | $225.06M | $226.26M | $239.28M | 57.7% | -4.9% |
| Non-U.S. revenue | $149.84M | $144.51M | $138.83M | $134.62M | $128.55M | $123.16M | $117.21M | $110.42M | $103.70M | $96.46M | $89.40M | $88.58M | 42.3% | +16.6% |
From the segment and revenue-disaggregation notes of Inogen's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.